← Leaderboards
Elizabeth Pearsall
Massachusetts Eye And Ear Infirmary
$1,597,016
Attributed
$1,597,016
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $391.3K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,597,016 · 3
By mechanism
R01$1,131,081 · 1
R56$391,250 · 1
F32$74,685 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Eye And Ear Infirmary
Same institution · by research overlap
- Margaret M Deangelis$3,722,941
- Thaddeus P Dryja$4,870,096
Others in their field
Other Emerging Leaders on “Link”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Susan M Landau · University Of California Berkeley$47,252,026
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,507,271
- Kathleen Maletic Neuzil · Emory University$25,301,215
- Anthony Philippakis · University Of California Santa Cruz$23,897,237
- Bronwen Shaw · Medical College Of Wisconsin$18,756,649
Research focus
LinkAge Related Macular DegenerationSeveritiesMetabolicComplicationChoroidIn VitroRetinaAnimalsVisionBlindnessAffectChoroidal NeovascularizationCoupledAnti-Inflammatory AgentsDietaryCell TypeBevacizumabBeta-HydroxybutyrateAngiogenesisBindingAdoptive TransferClinical ResearchBenchmarking
Grant awards (6)
A new class of wet AMD therapeutics$362,331
R01 · FY2025 · EY · contact PI
A new class of wet AMD therapeutics$377,500
R01 · FY2024 · EY · contact PI
A new class of wet AMD therapeutics$391,250
R01 · FY2023 · EY · contact PI
A new class of wet AMD therapeutics$391,250
R56 · FY2022 · EY · contact PI
Sex-Dependent Regulation of Retinal Degeneration$9,079
F32 · FY2021 · EY · contact PI
Sex-Dependent Regulation of Retinal Degeneration$65,606
F32 · FY2019 · EY · contact PI